Nanjing Leads Biolabs (HKG:9887) made a stellar trading debut in Hong Kong Friday morning as its shares opened 107% above the IPO price.
The clinical-stage biotech company opened at HK$72.40 per share, compared with the IPO price of HK$35.00.
Nanjing Leads Biolabs (HKG:9887) made a stellar trading debut in Hong Kong Friday morning as its shares opened 107% above the IPO price.
The clinical-stage biotech company opened at HK$72.40 per share, compared with the IPO price of HK$35.00.
Comments